Skip to main content
. Author manuscript; available in PMC: 2023 Nov 29.
Published in final edited form as: Int J Drug Policy. 2020 May 6;80:102748. doi: 10.1016/j.drugpo.2020.102748

Table 1.

Weighted Regions for Synthetic Uruguay

Chilean Regions Past Year Use Past Month Use Frequent Use (10+days/month) Among Users Perceived Availability Perceived Risk
Tarapaca −0.012 0.020 0.005 −0.025 0.003
Antofagasta 0.044 0.022 −0.001 0.175 0.016
Atacama 0.039 0.021 0.000 0.055 0.010
Coquimbo −0.030 −0.011 −0.001 −0.020 0.011
Valparaíso 0.021 0.019 −0.001 0.053 0.018
Bernardo O’higgins 0.002 0.013 −0.002 −0.062 0.019
Maulé 0.004 0.010 −0.002 −0.113 0.011
Bío Bío 0.016 0.003 −0.001 0.101 0.031
Araucania 0.007 −0.001 0.000 0.161 0.029
Los Lagos 0.081 0.043 0.000 0.086 0.022
Aysén 0.027 0.017 −0.002 0.131 0.035
Magallanes 0.028 0.036 −0.002 −0.147 0.042
R. Metropolitana 0.013 0.014 0.001 0.030 0.019
Los Ríos 0.039 −0.002 −0.001 0.067 −0.029
Arica y Parinacota 0.066 0.045 0.004 0.225 0.058
MSPE (Percentile) 6e-04 (6.7%) 3e-04 (6.7%) 6e-04 (93.3%) 3e-04 (13.3%) 3e-04 (26.7%)
*

Weights are from the models build using pre-intervention biennial survey data (through 2013).